Interestingly, immunohistochemical analysis carried out in two representative cases revealed a higher infiltration of CD8+ cells in the tumor microenvironment of a patient achieving a pCR compared to a partial responder (Additional file 4). The gene discussed is CD8A; the disease is neoplasm.